"This analysis explores the critical shifts in the sector, highlighting a projected growth trajectory driven by technological integration and changing consumer dynamics."

According to analysts at Vantage Market Research, the United States AI in Medical Imaging Market size is worth USD 2.8 Billion in 2025 and is projected to reach USD 18.9 Billion by 2035, growing at a CAGR (Compound Annual Growth Rate) of 21.1% from 2026 to 2035. Key trends include rising adoption of AI-powered diagnostic workflows, increasing radiologist workload, cloud-based imaging platforms, AI-enabled detection and triage, oncology imaging applications, enterprise-scale procurement, generative AI-assisted reporting, predictive analytics, and growing demand for interoperable imaging solutions across U.S. healthcare systems.

United States AI in Medical Imaging Market Overview

The United States AI in Medical Imaging Market is witnessing rapid expansion as healthcare providers increasingly integrate artificial intelligence into radiology workflows, diagnostic imaging operations, and enterprise healthcare infrastructure. AI-powered imaging solutions are transitioning from pilot-stage technologies into operational platforms that support radiologist productivity, diagnostic throughput, case prioritization, image reconstruction, quantification, and clinical decision support.

Rising imaging volumes combined with persistent pressure on radiology departments are creating strong demand for automated detection, triage, and workflow optimization technologies. Hospitals, integrated delivery networks, and diagnostic imaging centers are increasingly evaluating AI solutions based on measurable operational outcomes, including reduced report turnaround time, improved radiologist utilization, faster urgent-case identification, and enhanced imaging workflow efficiency.

Software Solutions currently represent the leading component segment due to their broad integration across radiology ecosystems. Cloud-Based deployment is expanding rapidly as multi-site imaging networks seek scalable computing environments, centralized AI governance, and reduced infrastructure maintenance requirements. Detection & Triage remains a major functional application as healthcare providers prioritize urgent case identification and streamlined workflow management.

Oncology Imaging represents a significant application area because cancer diagnosis and treatment monitoring require high volumes of repeated imaging and longitudinal analysis. Hospitals are also expanding AI adoption across cardiology and neurology, particularly for stroke triage, disease quantification, and predictive imaging analytics.

The competitive environment is increasingly shaped by FDA-cleared algorithms, interoperability with PACS, RIS, and EHR systems, modality coverage, cybersecurity, and enterprise integration capabilities. Vendors are moving beyond individual algorithms toward broader imaging orchestration platforms that combine detection, reconstruction, quantification, reporting, and predictive analytics.

Overall, the US AI in Medical Imaging Market is expected to register robust long-term growth as healthcare organizations prioritize diagnostic efficiency, scalable imaging infrastructure, and AI-enabled clinical workflows. Enterprise procurement, cloud migration, vertical specialization, and generative AI are expected to remain central to market development through 2035.

Key Takeaways from the Report

Rising radiologist workloads and increasing medical imaging volumes are accelerating the adoption of AI-enabled diagnostic and workflow solutions across the United States.
Software Solutions account for the largest component share at 46.3%, supported by broad integration across radiology workflows and lower implementation friction compared with hardware-intensive systems.
Cloud-Based deployment is advancing at a 24.7% CAGR as multi-site healthcare organizations seek scalable computing, centralized governance, and flexible AI infrastructure.
Detection & Triage represents 31.9% of implementation volume, reflecting strong demand for urgent case prioritization and workflow automation.
Oncology Imaging accounts for 28.6% of application demand due to high imaging intensity, repeated scans, and the growing use of AI for lesion analysis and treatment monitoring.
Hospitals remain the leading end-user segment because of high imaging volumes, centralized technology budgets, and integrated specialty departments.
Enterprise Volume Agreements are expanding as large healthcare networks consolidate AI procurement and seek bundled pricing and standardized technology environments.
Generative AI, predictive analytics, and multimodal imaging intelligence are creating new opportunities for automated reporting, clinical decision support, and workflow orchestration.
Interoperability, FDA compliance, HIPAA requirements, algorithm transparency, and cybersecurity remain important considerations influencing institutional procurement decisions.
Major vendors are increasingly differentiating themselves through modality coverage, regulatory depth, enterprise integration, cloud capabilities, and specialty-specific imaging applications.

Top Players

GE HealthCare
Siemens Healthineers
Philips Healthcare
Aidoc
ai
ai
Arterys
Zebra Medical Vision
Canon Medical Systems
Fujifilm Holdings
RadNet
Infervision

Recent Industry Development

January 2025 — GE HealthCare expanded AI-enabled imaging orchestration capabilities across acute care networks, supporting enterprise workflow standardization and broader integration of AI into diagnostic imaging operations.

Report Coverage

Our market research reports provide comprehensive insights that are essential for strategic decision-making. We cover all key aspects of the market, including dynamics such as drivers, restraints, opportunities, and challenges, alongside the latest industry trends. Our analysis includes an in-depth technology roadmap, product life cycle evaluation, and PESTLE analysis, ensuring a thorough understanding of the market environment. We also assess GDP growth outlooks, examine regional and national market landscapes, and evaluate the impact of major events such as the COVID-19 pandemic. Additionally, our reports feature a detailed competitive landscape, including company market shares and profiles, providing actionable intelligence to empower your business strategies.

Latest Announcements

May 2026 — Fujifilm Holdings expanded breast imaging AI analytics across outpatient diagnostic networks, supporting enhanced imaging analysis and workflow efficiency.